Safety and Immunogenicity of Single and Multiple Injections of the Therapeutic Vaccine TG1050 in NUC-Suppressed Chronic Hepatitis B (CHB) Patients: Unblinded Analysis of a Double-Blind, Placebo-Controlled Phase 1b Study

Claire Fournier, et al.
AASLD, The Liver Meeting 2018, November 2018 – Abstract available on the AASLD website
Download the poster here
Poster Presentation